Epidemiology and genotypes of plasmid-mediated AmpC β-lactamase produced by clinical isolates of Klebsiella pneumoniae in Korea

被引：0
|
作者：
Song, W.
Lee, C. H.
Kim, J. S.
Kim, H. S.
Uh, Y.
Lee, J.
Lee, K.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70510-1
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [31] NOVEL PLASMID-MEDIATED CEFTAZIDIMASE FROM KLEBSIELLA-PNEUMONIAE ISOLATES
    CHANAL, C
    LABIA, R
    SIROT, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (01) : 81 - 82
  • [32] Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China
    Chen, Jinyun
    Wang, Dairong
    Ding, Yueping
    Zhang, Lei
    Li, Xi
    MICROBIAL DRUG RESISTANCE, 2019, 25 (02) : 251 - 257
  • [33] Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 β-lactamase in Taiwan
    Yu, WL
    Cheng, KC
    Wu, LT
    Pfaller, MA
    Winokur, PL
    Jones, RN
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 362 - 363
  • [34] Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC
    Hanson, ND
    Thomson, KS
    Moland, ES
    Sanders, CC
    Berthold, G
    Penn, RG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) : 377 - 380
  • [35] Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia
    Matsumura, Y.
    Yamamoto, M.
    Matsushima, A.
    Nagao, M.
    Ito, Y.
    Takakura, S.
    Ichiyama, S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (08) : 1931 - 1939
  • [36] Microbiologic and Clinical Implications of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae with or without Plasmid-Mediated AmpC β-Lactamase DHA-1
    Lee, Chen-Hsiang
    Su, Lin-Hui
    Li, Chia-Chin
    Chien, Chun-Chih
    Tang, Ya-Fen
    Liu, Jien-Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) : 5395 - 5398
  • [37] Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia
    Y. Matsumura
    M. Yamamoto
    A. Matsushima
    M. Nagao
    Y. Ito
    S. Takakura
    S. Ichiyama
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1931 - 1939
  • [38] The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children’s hospitals in China
    H. Ding
    Y. Yang
    Q. Lu
    Y. Wang
    Y. Chen
    L. Deng
    A. Wang
    Q. Deng
    H. Zhang
    C. Wang
    L. Liu
    X. Xu
    L. Wang
    X. Shen
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 915 - 921
  • [39] Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiency
    Wang, Xuan Ding
    Cai, Jia Chang
    Zhou, Hong Wei
    Zhang, Rong
    Chen, Gong-Xiang
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (09) : 1196 - 1202
  • [40] A novel plasmid-mediated β-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Klebsiella pneumoniae
    Kwak, JH
    Kim, MY
    Choi, EC
    ARCHIVES OF PHARMACAL RESEARCH, 2001, 24 (06) : 590 - 596
12345